Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assay

Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) emerged as the causal agent of an endemic atypical pneumonia, infecting thousands of people worldwide. Although a number of promising potential vaccines and therapeutic agents for SARS-CoV have been described, no effective antiviral...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhou, Yanchen, Agudelo, Juliet, Lu, Kai, Goetz, David H., Hansell, Elizabeth, Chen, Yen Ting, Roush, William R., McKerrow, James, Craik, Charles S., Amberg, Sean M., Simmons, Graham
Format: Artigo
Language:Inglês
Published: Elsevier B.V. 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3205982/
https://ncbi.nlm.nih.gov/pubmed/21820471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2011.07.016
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items